Thurston Springer Miller Herd & Titak’s Merck MRK Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470K	Buy	3,656 +1,194	+48%	+$140K	0.17%	148
2026 Q1	$296K	Sell	2,462 -1,747	-42%	-$202K	0.12%	188
2025 Q4	$443K	Buy	4,209 +3,396	+418%	+$319K	0.15%	160
2025 Q3	$68.2K	Sell	813 -15,268	-95%	-$1.26M	0.14%	178
2025 Q2	$1.27M	Buy	16,081 +3,141	+24%	+$250K	0.16%	145
2025 Q1	$1.16M	Buy	12,940 +2,146	+20%	+$200K	0.2%	121
2024 Q4	$1.07M	Buy	10,794 +373	+4%	+$38.5K	0.22%	114
2024 Q3	$1.18M	Buy	10,421 +567	+6%	+$67.4K	0.33%	79
2024 Q2	$1.22M	Buy	+9,854	New	+$1.27M	0.38%	66

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's MRK Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Merck (MRK) stake by 48% in Q2 2026, buying an estimated $140K and bringing the position to 3,656 shares worth $470K. The position accounts for 0.17% of the portfolio, ranked #148.

Thurston Springer Miller Herd & Titak first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.27M in Q2 2025. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Thurston Springer Miller Herd & Titak held 3,656 shares of Merck worth $470K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 1,194 Merck shares in Q2 2026, an estimated $140K.
Merck made up 0.17% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #148 holding.
Thurston Springer Miller Herd & Titak first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's Merck position peaked at $1.27M in Q2 2025.
1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.